VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 175 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $77,968 | -54.0% | 8,321 | +20.3% | 0.00% | -50.0% |
Q2 2023 | $169,649 | +25.6% | 6,916 | +19.2% | 0.01% | +20.0% |
Q1 2023 | $135,036 | -20.2% | 5,803 | 0.0% | 0.01% | -28.6% |
Q4 2022 | $169,215 | +62.7% | 5,803 | +6.7% | 0.01% | +40.0% |
Q3 2022 | $104,000 | -24.6% | 5,439 | 0.0% | 0.01% | -16.7% |
Q2 2022 | $138,000 | +14.0% | 5,439 | +15.4% | 0.01% | +50.0% |
Q1 2022 | $121,000 | -38.6% | 4,713 | 0.0% | 0.00% | -42.9% |
Q4 2021 | $197,000 | -3.9% | 4,713 | 0.0% | 0.01% | 0.0% |
Q3 2021 | $205,000 | -8.1% | 4,713 | 0.0% | 0.01% | -12.5% |
Q2 2021 | $223,000 | 0.0% | 4,713 | +8.1% | 0.01% | 0.0% |
Q1 2021 | $223,000 | +82.8% | 4,358 | -4.6% | 0.01% | +33.3% |
Q4 2020 | $122,000 | -22.3% | 4,566 | 0.0% | 0.01% | -14.3% |
Q3 2020 | $157,000 | -6.5% | 4,566 | +11.6% | 0.01% | -12.5% |
Q2 2020 | $168,000 | +700.0% | 4,090 | +559.7% | 0.01% | +700.0% |
Q1 2020 | $21,000 | +162.5% | 620 | 0.0% | 0.00% | – |
Q4 2019 | $8,000 | – | 620 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $40,100,000 | 21.56% |
SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $571,412,000 | 2.71% |
Nan Fung Group Holdings Ltd | 210,563 | $5,416,000 | 2.57% |
Taikang Asset Management (Hong Kong) Co Ltd | 533,332 | $13,717,000 | 2.34% |
Crawford Lake Capital Management, LLC | 168,200 | $4,326,000 | 1.80% |
BOULDER HILL CAPITAL MANAGEMENT LP | 126,900 | $3,264,000 | 1.75% |
Zebra Capital Management LLC | 22,227 | $572,000 | 1.31% |
Alaska Permanent Fund Corp | 2,300,000 | $59,156,000 | 0.98% |
CLARK ESTATES INC/NY | 180,000 | $4,630,000 | 0.73% |
Temasek Holdings (Private) Ltd | 5,602,553 | $144,097,663 | 0.61% |